These articles appeared in the July supplement of Trends in COPD.
Best Practices for COPD
By Gustavo Ferrer, MD; J. Ryan Schroeder, DO; Anas Hadeh, MD; and Jose F. Ramirez, MD
1. Sutherland ER, Cherniack RM. Management of chronic obstructive pulmonary disease. N Engl J Med. 2004;350(26):2689-2697.
2. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD. http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html. Updated 2013.
3. Centers for Disease Control and Prevention. National Center for Health Statistics. National vital statistics reports. 2012;61(7).
4. U.S. Department of Health and Human Services. National Institutes of Health. National Heart Lung and Blood Institute. Morbidity and mortality: 2009 chartbook on cardiovascular, lung and blood diseases.
5. Pena VS, Miravitlles M, Gabriel R, et al. Geographic variations in prevalence and underdiagnosis of COPD: Results of the IBERPOC multicentre epidemiological study. Chest. 2000;118(4):981-989.
6. Talamo C, de Oca MM, Halbert R, et al. Diagnostic labeling of COPD in five latin american cities. Chest. 2007;131(1):60-67.
7. Kessler R, Partridge MR, Miravitlles M, et al. Symptom variability in patients with severe COPD: A pan-european cross-sectional study. Eur Respir J. 2011;37(2):264-272.
8. Simel D, Rennie D. The rational clinical examination: Evidence-based clinical diagnosis. New York: McGraw Hill; 2008.
9. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: Systematic review and meta-analysis. Eur Respir J. 2006;28(3):523-532.
10. Raad D, Gaddam S, Schunemann HJ, et al. Effects of water-pipe smoking on lung function: A systematic review and meta-analysis. Chest. 2011;139(4):764-774.
11. Tetrault JM, Crothers K, Moore BA, Mehra R, Concato J, Fiellin DA. Effects of marijuana smoking on pulmonary function and respiratory complications: A systematic review. Arch Intern Med. 2007;167(3):221-228.
12. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med. 2001;163(5):1256-1276.
13. Kesten S, Chapman KR. Physician perceptions and management of COPD. Chest. 1993;104(1):254-258.
14. Loveridge B, West P, Kryger MH, Anthonisen NR. Alteration in breathing pattern with progression of chronic obstructive pulmonary disease. Am Rev Respir Dis. 1986;134(5):930-934.
15. Qaseem A, Wilt TJ, Weinberger SE, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: A clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society and European Respiratory Society. Ann Intern Med. 2011;155(3):179-191.
16. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347-365.
17. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128-1138.
18. Anthonisen NR. Smoking and lung function of lung health study participants after 11 years. American Journal of Respiratory and Critical Care Medicine. 2002;166(5):675 <last_page> 679.
19. Appleton S, Poole P, Smith B, Veale A, Lasserson TJ, Chan MM. Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006;(3)(3):CD001104.
20. Barr RG, Bourbeau J, Camargo CA, Ram FS. Inhaled tiotropium for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2005;(2)(2):CD002876.
21. Tashkin DP, Pearle J, Iezzoni D, Varghese ST. Formoterol and tiotropium compared with tiotropium alone for treatment of COPD. COPD: Journal of Chronic Obstructive Pulmonary Disease. 2009;6(1):17-25.
22. Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356(8):775-789.
23. Fabbri LM, Calverley PM, Izquierdo-Alonso JL, et al. Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: Two randomised clinical trials. The Lancet. 2009;374(9691):695-703.
24. Welte T, Miravitlles M, Hernandez P, et al. Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180(8):741-750.
25. Berry MJ, Rejeski WJ, Adair NE, Zaccaro D. Exercise rehabilitation and chronic obstructive pulmonary disease stage. Am J Respir Crit Care Med. 1999;160(4):1248-1253.
26. Wongsurakiat P, Maranetra KN, Wasi C, Kositanont U, Dejsomritrutai W, Charoenratanakul S. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: A randomized controlled study. Chest. 2004;125(6):2011-2020.
27. Advisory committee on immunization practices (ACIP) recommended immunization schedule for adults aged 19 years and older – United States, 2013. http://www.cdc.gov/mmwr/preview/mmwrhtml/su6201a3.htm. Accessed 3/3/2013, 2013.
28. Celli BR, Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. Eur Respir J. 2007;29(6):1224-1238.
29. Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J. 2005;26(6):1138-1180.
30. Plant P, Owen J, Elliott M. Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: A multicentre randomised controlled trial. The Lancet. 2000;355(9219):1931-1935.
31. Puhan MA, Gimeno-Santos E, Scharplatz M, Troosters T, Walters EH, Steurer J. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011;(10):CD005305. doi(10):CD00530.
Screening Practices to Promote Earlier Diagnosis of COPD
By Chris Garvey, FNP, MSN, MPA, FAACVPR
2. Heron M. Deaths: leading causes for 2008. National Vital Statistics Reports. http://www.cdc.gov/nchs/data/nvsr/nvsr60/nvsr60_06.pdf
3. Mannino DM, et al.Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWRSurveill Summ. 2002;51(6):1-16.
4. WHO. The top 10 causes of death.http://www.who.int/mediacentre/factsheets/fs310/en/index.html
5. Barr R, et al. Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. Am J Med.2009;122(4):348-355.
6. GOLD Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. http://www.goldcopd.org/uploads/users/files/GOLD_Report_2013_Feb20.pdf.
7. WHO. Chronic obstructive pulmonary disease (COPD). 2013. http://www.who.int/mediacentre/factsheets/fs315/en.
8. Martinez F, Raczek A, Seifer F, Conoscenti C, Curtice T,.et al. Development and Initial Validation of a Self-Scored COPD Population Screener Questionnaire (COPD-PS). Journal of COPD. 2008;5(2):85-95.
9. Jones et al. European Respiratory Journal 2009; 34: 648-654.
10. The COPD Assessment Test healthcare professional user guide: expert guidance on frequently asked questions. Jones PW, Jenkins C, Bauerle O (on behalf of the CAT Development Steering Group).
11. Hanania NA, et al. Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ). Respir Med.2010;104(8):1160-1170.
12. Han MK, et al. Spirometry utilization for COPD: how do we measure up? Chest. 2007;132(2):403-409.
13. Belfer MH. Office management of COPD in primary care: a 2009 clinical update. Postgrad Med. 2009;121(4):82-90.
14. Yawn B, Wollan P. Knowledge and attitudes of family physicians coming to COPD continuing medical education. Int J Chron Obstruct Pulmon Dis.2008;3(2):311-317.
15. Garvey CC. Best practices in chronic obstructive pulmonary disease. Nurse Pract 2011;36(5):16-22.
16. Donaldson G, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57(10):847-852.
17. Kelly C. An overview of acute exacerbations of COPD. Nurs Times. 2009;105(13):25-28.
Educating Patients with COPD
By Mary Hart, MSHCA, RRT, AE-C, FAARC
1. About COPD. Available at: www.copdfoundation.org/COPDYou/AboutCOPD/aspx. March 11, 2013.
2. Gallefoss, Bakke. Impact of patient education and self-management on morbidity in asthmatics and patients with chronic obstructive pulmonary disease. Respiratory Medicine 2000; 94:279-287.
3. Global Strategy for the diagnosis, management and prevention of COPD. March 8, 2013. http://www.goldcopd.org/.
4. COPD Pocket Guide. March 8, 2013. http://www.goldcopd.org/.
5. How to use Asthma and COPD Inhalers. March 9, 2013. http://www.yourlunghealth.org/.
6. Big Fat Reference Guide. March 9, 2013. http://www.copdbfrg.org/
7. Partnering with Patients for Successful COPD Care. AARC Times, 2010; 98-99.
8. Living Well With COPD: Chronic Bronchitis and Emphysema Patient Education Guide. American College of Chest Physicians and The Chest Foundation. Printed Educational Material.
Putting Pulmonary Rehabilitation into Perspective
By Linda Nici, MD, and Richard ZuWallack, MD
1. Celli BR, MacNee W, Agusti A, Anzueto A, Berg B, Buist AS, Calverley PMA, Chavannes N, Dillard T, Fahy B, Fein A, Heffner J, Lareau S, Meek P, Martinez F, McNicholas W, Muris J, Austegard E, Pauwels R, Rennard S, Rossi A, Siafakas N, Tiep B, Vestbo J, Wouters E. ZuWallack R. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23:932-946.
2. American Thoracic Society and European Respiratory Society. Standards for the diagnosis and management of patients with COPD 2004; http://www.thoracic.org/.
4. Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, Make B, Rochester CL, ZuWallack R, Herrerias C. Pulmonary rehabilitation. Joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest 2007; 131:4S-42S.
5. Nici L, Donner C, ZuWallack R, Wouters E, et al. The ATS/ERS Statement on Pulmonary Rehabilitation. Am J Respir Crit Care Med. 2006; 173: 1390-1414.
6. Casaburi R, ZuWallack R. Pulmonary rehabilitation for the management of chronic obstructive pulmonary disease. N Engl J Med. 2009;360(13):1329-35.
7. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The body mass index, airflow obstruction, dyspnea and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005-12.
8. American Association of Cardiovascular & Pulmonary Rehabilitation. Guidelines for pulmonary rehabilitation programs / American Association of Cardiovascular & Pulmonary Rehabilitation. Crouch R and ZuWallack R, editors; 4th ed. 2010; Human Kinetics.
9. American Thoracic Society, European Respiratory Society. ATS/ERS statement on skeletal muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159:S1-S40.
10. Bernard S, Leblanc P, Whittom F et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158(2):629-634
11. Engelen MP, Schols AM, Does JD et al. Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 2000;71(3):733-738.
12. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD.Am J Respir Crit Care Med 1996; 153:976-980.
13. Sala, E., J. Roca, R. M. Marrades, J. Alonso, J. M. Gonzalez de Suso, A. Moreno, J. A. Barbera, J. Nadal, L. de Jover, R. Rodriguez-Roisin, and P. D. Wagner. Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159:1726-1734.
14. American college of sports medicine. Position stand. The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness in healthy adults. Med. Sci. Sports Exerc. 1990 ; 22:265-274.
15. Maltais F, LeBlanc P, Jobin J, et al. Intensity of training and physiologic adaptation in patient with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 155: 555-561.
16. Casaburi R., A. Patessio, F. Ioli, S. Zanaboni, C. F. Donner, and K. Wasserman. Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am. Rev.Respir. Dis. 1991; 143:9-18.
17. Casaburi, R., D. Kukafka, C.B. Cooper, T.J. Witek and S. Kesten. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest. 2005;127:809-817.
18. Vogiatzis I, Nanas S, Roussos C. Interval training as an alternative modality to continuous exercise in patients with COPD. Eur Respir J. 2002;20:12-19.
19. O’Donnell DE, D’Arisigny C, Webb KA. Effects of hperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163:892-898.
20. Bernard S, Whittom F, LeBlanc P, Jobin J, Belleau R, Berube C, Carrier G, Maltais F. Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159:896-901.
21. Lacasse Y, L Brosseau, S Milne, S Martin, E Wong, GH Guyatt, RS Goldstein. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2002; 3: CD003793.
22. Bourbeau J. The role of collaborative self management in pulmonary rehabilitation. Semin Respir Crit Care Med. 2009 Dec;30(6):700-7.
23. www.livingwellwithcopd.com/
24. Heffner JE, Fahy B, Barbieri C. Advance directive education during pulmonary rehabilitation. Chest. 1996;109(2):373-9.
25. Heffner JE, Fahy B, Hilling L, Barbieri C. Outcomes of advance directive education of pulmonary rehabilitation patients. American Journal of Respiratory and Critical Care Medicine 1997;155(3):1055-9.
26. Bourbeau J, Julien M, Maltais F et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med 2003; 163(5):585-591.
27. Coventry PA. Does pulmonary rehabilitation reduce anxiety and depression in chronic obstructive pulmonary disease? Curr Opin Pulm Med. 2009; 15:143-149.
28. Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, et al. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008; 134(4 Suppl):43-56S.
29. Kozora E, Emery CF, Zhang L, Make B. Improved neurobehavioral functioning in emphysema patients following medical therapy. J Cardiopulm Rehabil Prev. 2010; 30:251-259.
30. 1.Celli BR, Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. Eur Respir J. 2007;29:1224-1238.
31. Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK. Randomised, double-blind, placebo-controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ. 2000;320:1297-1303.
32. Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M; UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008; 359:1543-1554.
33 .Garcia-Aymerich J, Hernandez C, Alonso A, Casas A, Rodriguez-Roisin R, Anto JM, Roca J. Effects of an integrated care intervention on risk factors of COPD readmission. Resp Med. 2007; 101(7):1462-9.
34. Rice KL, Dewan N, Bloomfield HE, et al. Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med. 2010;182(7):890-6.
35. Troosters T, Probst VS, Crul T, et al. Resistance training prevents deterioration in quadriceps muscle function during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010; 181(10):1072-7.
36. Nici L, R ZuWallack. An Official ATS Workshop Report: The Integrated Care of the COPD Patient. Proc Am Thorac Soc. 2012; 9(1): 9-18
37. Casas A, Troosters T, Garcia-Aymerich J, Roca J, Hernandez C, Alonso A, del Pozo F, de Toldeo P, Anto JM, Rodriguez-Roisin R, Decramer M. Integrated care prevents hospitalisations for exacerbations in COPD patients. Eur Respir J. 2006; 28:123-130.
38. Puhan M, Scharplatz M, Troosters T, Walters EH, Steurer J. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2009; Issue 1. Art. No. CD005305 DOI:10.1002/14651858.CD005305.pub2.
39. Grone O, Garcia-Barbero M. Integrated care. A position paper of the WHO European office for integrated healthcare services. Internat J Integrated Care. 2001; 1:1-15.
